hai Drug design Conferences | Meetings | Events | Symposiums | ConferenceSeries

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

 

Recommended Conferences for Drug design

Drug design


As per available reports about 43 relevant Journals, 38 Conferences,  Workshops are presently dedicated exclusively to drug design and about 1269 articles are being published on drug design.

Drug design  discovery and development is an intense, lengthy and an interdisciplinary endeavor. Drug discovery is mostly portrayed as a linear, consecutive process that starts with target and lead discovery, followed by lead optimization and pre-clinical in vitro and in vivo studies to determine if such compounds satisfy a number of pre-set criteria for initiating clinical development. New fields have arisen such as pharmacogenetics and pharmacogenomics and are touching the goals and guiding principles of drug design and drug discovery.

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.  

Scope and Importance:

Drug Design Conference provides the scope for opportunities to learn progressed by international scientists and academicians. an explosion of genomic information, which is revolutionizing the way drug discovery takes place. Moreover, new fields have arisen such as pharmacogenetics and pharmacogenomics and are touching the goals and guiding principles of drug design and discovery. 

Drug design  discovery and development is an intense, lengthy and an interdisciplinary endeavor. Drug discovery is mostly portrayed as a linear, consecutive process that starts with target and lead discovery, followed by lead optimization and pre-clinical in vitro and in vivo studies to determine if such compounds satisfy a number of pre-set criteria for initiating clinical development. For the pharmaceutical industry, the number of years to bring a drug from discovery to market is approximately 12-14 years and costing upto $1.2 - $1.4 billion dollars. Traditionally, drugs were discovered by synthesizing compounds in a time-consuming multi-step processes against a battery of in vivo biological screens and further investigating the promising candidates for their pharmacokinetic properties, metabolism and potential toxicity. Such a development process has resulted in high attrition rates with failures attributed to poor pharmacokinetics (39%), lack of efficacy (30%), animal toxicity (11%), adverse effects in humans (10%) and various commercial and miscellaneous factors. Today, the process of drug discovery has been revolutionized with the advent of genomics, proteomics, bioinformatics and efficient technologies like, combinatorial chemistry, high throughput screening (HTS), virtual screening, de novo design, in vitro, in silico ADMET screening and structure-based drug design.

Market Analysis:

The global market for sequencing products and services reached $3.5 billion in 2012. This market is expected to grow to nearly $4.5 billion in 2013 and nearly 11.7 billion in 2018, a compound annual growth rate (CAGR) of 21.2%.

Symposium:

  • 1st International Gazi Pharma Symposium Series to be held from November 12 to 15, 2015 in Antalya, Turkey.
  • XII International Pharma Licensing Symposium (XII IPLS)
  • International symposium and workshops in November 12, 2014 by New Zealand Drug Foundation
  • IV International Symposium on Drug Discovery in July 22th to 24th, 2015 held at the School of Pharmaceutical Sciences (UNESP), Araraquara, São Paulo, Brazil,
  • International Symposium on Drug Policy and Public Health on 29 September - 1 October 2014 Istanbul, Turkey

List of Best International Conferences:

Associations

  • Bioanalytical Focus Group and Ligand Binding Assay
  • American Association of Pharmaceutical Scientists (AAPS)
  • Royal Netherlands Chemical Society
  • The European Bioanalysis Forum
  • BEBAC Consultancy Services for Bioequivalence and Bioavailability
  • American Thyroid Association
  • Generic Pharmaceutical Association
  • FDA
  • European Generic medicines Association.
  • Therapeutics Goods Administration (TGA)
  • European Economic Area
  • Canadian Generic Pharmaceutical Association (CGPA)
  • Bioequivalence and Bioavailability forum
  • FDA Office of Surveillance and Epidemiology (formerly Drug Safety)
  • Drug Watch
  • ORPHANET Parenteral Drug Association
  • PharmGKB
  • US Food and Drug Administration (FDA)
  • American Association for Clinical Chemistry (AACC)
  • American Association of Pharmaceutical Scientists (AAPS)
  • Clinical Trials Information from National Institutes for Health (NIH)
  • National Institute of Standards and Technology (NIST)

Companies :

  • Myriad RBM, Inc
  • NDI ADRL Inc. dba Diteba
  • BioScience Laboratories, Inc.
  • Pacific BioLabs (PBL)
  • Biological Test Center
  • Algorithme Pharma, Inc.
  • Gateway Analytical
  • Celerion
  • Apotex Inc.
  • PharmaNet Development Group, Inc
  • AstraZeneca
  • Accredo Therapeutics
  • Actelion Pharmaceuticals US, Inc
  • Bayer HealthCare
  • CRITICAL CARE
  • Cané Medical Technology
  • CVS Caremark
  • CuraScript
  • Fairview Specialty Pharmacy
  • Gilead Sciences

This page will be updated regularly.

This page was last updated on November 5, 2024

Conference Series Destinations